BioSpace News Archive

Helix Biopharma To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland

September 29, 2014
·
1 min read
Nanovi Secures EUR2.7M To Market BioXmark And Expands Board Of Directors

September 29, 2014
·
4 min read
Drug Development

Genentech’s Investigational Combination Of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone

September 29, 2014
·
1 min read
Deals

Ex-Elan Corporation PLC Trio Snags Their Former Employer’s Kinase Inhibitor Program

September 29, 2014
·
1 min read
Drug Development

Seattle Genetics, Inc. To Host Conference Call And Webcast On September 29, 2014 Regarding Top-Line Data From ADCETRIS® (brentuximab vedotin) Phase 3 AETHERA Clinical Trial

September 29, 2014
·
1 min read
Drug Development

Seattle Genetics, Inc. And Takeda Pharmaceutical Co. Ltd. Announce Positive Data From Phase 3 AETHERA Clinical Trial Of ADCETRIS® (Brentuximab Vedotin) For Consolidation In Post-Transplant Hodgkin Lymphoma

September 29, 2014
·
1 min read
Deals

Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC

September 29, 2014
·
2 min read
Deals

New U.S. Tax Rules May Lead Medtronic, Inc. To Redo Covidien plc Deal

September 29, 2014
·
1 min read
Drug Development

Novartis AG Drug Afinitor Is First Treatment For Advanced Pancreatic NET To Provide Overall Survival Of More Than 3.5 Years In Phase 3 Trial

September 29, 2014
·
12 min read
Business

Novartis AG Oversees Distant Regions From Miami Headquarters

September 29, 2014
·
1 min read